While Bydureon and Ozempic can be effective medications for managing type 2 diabetes, it is important to be aware of potential side effects that may occur
Future prospectively designed longitudinal studies should include a longitudinal aspect from the outset to increase retention and balance the time between study visits between groups
It could improve cardiometabolic outcomes at scale in a country carrying one of the worlds largest burdens of obesity and type 2 diabetes
Individual results vary based on lifestyle modifications, metabolic factors, and adherence to weight maintenance strategies implemented after discontinuation
1D), followed by isoleucine, tryptophan, arginine, and valine
MAFLD: a comprehensive review of the link between metabolic dysfunction and cardiovascular risk